Clinical Trial Update: JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer [Phase 3]

View source ↗

Summary

Clinical trial update for JoLT-Ca comparing Sublobar Resection versus Stereotactic Ablative Radiotherapy in non-small cell lung cancer; the Phase 3 study is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Non-Small Cell Lung Cancer | Phase 3 | Status: RECRUITING